Multi-region whole-exome sequencing of 100 early stage NSCLC patients demonstrated that clonal alterations of oncogenes such as the growth receptor EGFR and the kinases MET, and BRAF were commonly found in ADC (Jamal-Hanjani et al., 2017). This evidence concerns the gene MET and non-small cell lung carcinoma.